Alternatives to Owkin

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

Traditional evidence generation methods are expensive, complex, and take too long to generate. This prevents agile research and the wider utilization of authentic patient insights in treatment development and commercial pipelines. Our HyperStream is the largest real-time data stream of patient experience on earth. It records the real-world digital history and symptoms of diseases as they are shared online by authentic patients. Pharos, a web-based evidence generator tool and research framework, uses its integrated data streaming technology and AI capabilities to efficiently capture online patients experience data and enables teams and individuals to quickly find evidence when they need it. The Pharos Suite has been successfully used to generate evidence and patient insight in multiple therapeutic areas and diseases.

Artificial intelligence transforms healthcare diagnosis Predictive analytics and AI are used to detect early-stage diseases and provide accurate diagnosis. Cloud-enabled AI platform to provide affordable and accessible healthcare. Endimension Technology, a startup in healthcare artificial intelligence, was founded at IIT Bombay. AI algorithms are developed to automatically detect abnormalities in medical scans and diagnose diseases. The founding team includes machine learning researchers, software engineers, and medical doctors from well-respected institutions. Our mission is to develop healthcare AI technology products that reduce misdiagnosis. AI to reduce the workload of radiologists Improve patient turnaround time

We are an artificial intelligence-enabled SaaS which diagnoses drug-resistant tuberculosis within a matter of hours. AarogyaAI aims at diagnosing drug-resistant tuberculosis using Artificial Intelligence within a few hours. We allow rapid and accurate diagnosis of DRTB so that patients can be prescribed the most effective drug combinations. Tuberculosis kills more people each year than AIDS. Because there are 19 anti-TB medications available, doctors don’t always know which one will work for whom. Even though tuberculosis may be curable, patients who are not diagnosed in time can end up on ineffective treatment for up to seven years. AarogyaAI is able to diagnose drug-resistant tuberculosis within a few hours, so that patients can be prescribed effective treatment immediately. Our SaaS uploads the patient's DNA sequence. The machine learning algorithm generates an output report that shows a complete drug susceptibility status.

Altis Labs launches Nota, a clinical information platform that accelerates R&D for therapeutics. AI predicts patient outcomes based on imaging data, so sponsors can prioritize their most promising treatments. Nota allows researchers to access imaging biomarkers and speed up R&D by operationalizing clinical trial imaging data. Altis' cloud software platform powered with deep learning allows biopharma to incorporate comprehensive outcomes predictions at the image level, patient level, and cohort-level in order to improve clinical trial designs and better anticipate clinical endpoints. These insights can accelerate drug development timelines and lower costs, while increasing the likelihood of success in clinical trials across therapeutic areas.

To drive precision medicine programs that work, pharmaceutical companies require comprehensive genomic information. However, decisions are often made with only 10% of the data available. Genomenon provides 100% of the data. ProdigyTM Patient Landscapes are a cost-effective and efficient natural history research solution for pharmaceuticals. They enhance insights from retrospective and prospective health data to support the development rare disease therapies. Genomenon uses an AI-driven approach to deliver a thorough and expert assessment of all patients in the medical literature in a fraction time. Get a complete overview of every genomic biomarker in the medical literature. Every scientific assertion is supported with empirical evidence from medical literature. Identify all genetic drivers and determine which variants are pathogenic according ACMG clinical standards.

Our AI products are designed for healthcare professionals to help them at critical moments in their medical journey. We enable seamless workflow optimization throughout the care continuum, including preventive screenings, early detection and emergency care. Our AI is built in collaboration with top healthcare professionals and training algorithms that process unprecedented amounts of data. Our solutions are backed by deep data science research to anticipate your care needs and assist you in limited circumstances. Our AI solutions can be deployed wherever and whenever needed. They are compatible with any device and can integrate with existing technological infrastructure. We offer easy deployment and scaling, as well as industry-certified data security. Our team is here to help you at every stage of your AI journey.

RetinAI's software discovery platform is used by healthcare professionals and pharmaceutical companies to manage their data and gain enhanced insights through automatic AI analysis. It also supercharges clinical and research workflows. A single data platform that allows you to access and manage your data from anywhere at any time. Compatible formats include DICOM compliant and proprietary formats. AI is used to harmonize, organize, aggregate & analyze data at scale in order to extract insights into disease progression, treatment outcome & progression prediction. Secure cloud-based data access allows for collaborative research across your organization. The central hub for data, digital, and medical teams. Perform AI-based analyses on your OCT volume for layer and fluid segmentation. Centralize your insights and provide immediate evaluation in a single platform. Invite collaborators instantly to access and work on datasets with different levels of permission.

Cleerly, a digital healthcare company, is changing the way that clinicians approach heart disease treatment. We create intelligent clinical technologies that help clinicians identify and define atherosclerosis sooner, so they can provide personalized, vital treatment plans for all patients. Atherosclerosis is plaque buildup in the heart's vessels. We do not use indirect markers like risk factors or symptoms to diagnose the disease. Our AI-enabled digital healthcare pathway makes it easier, faster, and more accurate to diagnose and report heart disease. This improves overall clinical and financial outcomes. Cleerly empowers providers by analyzing, characterizing and quantifying plaque types. This allows them to more accurately determine the risk of heart attacks and to develop a treatment plan for improving heart health.

Deliver personalized patient care using the only objective, quantitative, and histologically validated arterial analysis software based on CTA. Use ground-truth histology in order to visualize the cause of myocardial ischaemia and to inform heart attack and stroke risks. Undiagnosed, untreated non-obstructive but unstable plaques in the arteries are the primary cause of heart attack and stroke. Current non-invasive tests cannot visualize the biology deep within artery walls, where heart disease develops. Elucid uses artificial intelligence and scientific imaging to provide noninvasive, quick diagnoses of cardiovascular disease and precise treatment. This will improve patient outcomes. Assess plaque composition using histology-validated computer software. With greater accuracy, quantify heart attack and stroke risks. Visualize a comprehensive, objective view of arterial diseases to enable personalized treatment before a patient enters the hospital.

BIOiSIMTM, a revolutionary 'virtual drug engine', is the first-in-class tool that allows drug developers to narrow down the number drugs that have potential value in treating or curing specific diseases or illnesses. We offer a variety of translational-based solutions that can be customized for your clinical and pre-clinical programs. All of these solutions are based on our BIOiSIMTM platform, which is a proven and validated platform for small molecules, large molecule, and viruses. Our models are built using data from thousands upon thousands of compounds across seven species, which gives them a robustness that is rare in the industry. The platform is focused on human outcomes and has at its core a translatability tool that transforms insights across species. The BIOiSIMTM platform is available before preclinical animal trials begin, which allows for earlier insights and saves on expensive outsourced experimentation.

We are introducing a new era in predictive analytics, starting with healthcare data management, machine-learning tools and custom-built applications for the healthcare industry. Lumiata's superior cost- and risk prediction are designed with healthcare delivery and business in mind. They are revolutionizing the way risk and care are managed across the wider healthcare industry. Lumiata covers everything, from underwriting to care management to pharmaceuticals. Our applications and data science tools allow for a flexible partnership with payers, providers, digital healthcare companies, and other stakeholders. You have reached the end of the tunnel. Equip your data science teams the ML productivity tools that they need. Our proprietary data preparation and cleansing process allows raw data to be ingested and cleansed before being organized into a consumable format that is ready for machine learning.

Collaboration between doctors, scientists, cancer centers, patients and physicians is key to improving the quality of cancer care and outcomes. Oncora's intuitive platform software allows all stakeholders to collect and apply real-world data to all healthcare-related decisions for the benefit of patients. Our products are designed for healthcare professionals who want to improve the outcomes of cancer patients. Intelligent patient care software simplifies workflow, reduces documentation burden, optimizes treatment, and improves outcomes. With intuitive and dynamic software tools, you can capture and visualize real-world data that is of regulatory quality. Advanced reporting tools allow you to measure quality and streamline operations in order to improve patient care. Experts in cancer care conduct rigorous clinical research. Web-based software that empowers your cancer center. Data and software to speed up clinical discoveries.

We are a biotechnology company in clinical stage. We decode biology by integrating technological innovations across biology and chemistry to industrialize drug discovery. CRISPR genome editing and synthetic Biology allow for greater control over biology. Advanced robotics allows for reliable automation of complex laboratory research on an unprecedented scale. Neural network architectures allow for iterative analysis and inference from large, complex, in-house data sets. Cloud solutions increase the flexibility of high-performance computation. To build a next-generation biopharmaceutical business, we are using new technology to create virtuous learning cycles around datasets. A synchronized combination hardware, software, and data that is used to industrialize drug discovery. Redefining the traditional drug discovery process. One of the most extensive, broadest, and deepest pipelines in any technology-enabled drug company.

WRDensity aids radiologists in interpreting breast densities to ensure uniform density assessments at the practice level. Its goal is to aid in early detection1 and give patients peace of mind through consistency, confidence, quality, and care. WRDensity was trained with deep learning based upon over 600,000 images taken by Mallinckrodt Institute of Radiology. This is one of the most respected radiology research institutes in the world. WRDensity's powerful deep-learning model is able to accurately classify breast density. The batching and sorting feature of WRDensity can increase productivity by up to 20% for users. WRDensity can be accessed within the existing workstation of radiologist, making relevant information about tissue density available in context.

Many decisions regarding cancer care are uncertain. Current tools are not helpful for the majority of patients. This is leading to unnecessary deaths and wasted money. We are a multidisciplinary team of computer scientists and oncologists who help to tackle the most pressing issues in cancer care using AI. We are developing clinical-grade deep learning to analyze each patient's unique characteristics and provide clarity to the oncologists during decision-making. Our AI was developed with oncologists at our center and provides actionable and interpretable insights. We collaborate with top academic medical centers as well as community oncologists to address clinically important questions.

Zebra's Imaging Analytics Engine automatically analyzes images from different modalities for clinical findings. It does this in a timely fashion and in full synergy to radiology workflow. Zebra-Med alerts providers of patients at high risk for cardiovascular, lung, bone, and other diseases. This allows for preventative care programs, proper risk adjustment and allocation, as also conformance to quality standards like MACRA. Zebra-Med allows for the right patient to be seen at the right time, saving money and improving care.

Genospace understands that genomics is driving precision medicine development, but scaling its delivery remains a challenge. We are here to help. Our platform makes biomedical data meaningful, accessible and easy to use for everyone, especially those at the frontlines of care delivery. Your clinicians and researchers will have the information they need in order to make informed decisions. Join us in our mission to leverage high-dimensional molecular data to improve patient outcomes and accelerate drug discovery and research. For drug development and research, large-scale population data is essential. Genospace platform allows you to conduct cohort-driven analyses that will inform your research activities. We are experts in clinical trial research. Genospace allows you to quickly accrue patients by matching fragmented patient data with complex trial criteria. The Genospace platform enables you to integrate genomic medicine into your mainstream clinical care.

Use AI to accelerate the journey from bench-research and laboratory insights to life-changing therapies. Reduce your reading time to minutes and gain up to 90% more research productivity. With a high-precision and high-accuracy research, you can cut through the noise to navigate the ever-growing amount of scientific literature. Save time, reduce bias, and increase the odds of discovering novel things. Explore disease biology in depth and discover advanced targets. Causaly’s high-precision graph of knowledge consolidates evidence from millions publications, allowing for unbiased, deep scientific exploration. You can navigate cause-and effect relationships in biology without being an expert. Discover hidden connections by viewing all scientific documents. Causaly’s powerful AI machine is able to read millions of published biomedical publications in order to support better research and decision-making.

Medical AI is an effective technology solution for chronic diseases. This technology is characterized by its ability to predict and generate the best actions. It also presents the outputs with an easy-to consume user experience. DeLorean Medical AI enhances human capabilities, and creates a world where we can both trust the machine and human to make the right decisions. Our technology has shown to improve outcomes, and is the first AI that has been biologically validated by third-party clinical testing. Medical AI can help diagnose and detect diseases earlier by predicting disease states, assigning risk and classifying patient populations. It can reduce costs. It has been installed by 10+ clients and has shown both cost reductions as well as savings.

Story Health uses AI technology and virtual care to bridge the gap between patient reality and clinical data. This allows specialists to optimize treatment for patients suffering from serious illnesses. The majority of a patient's story is not told in a doctor’s office. This has resulted in disjointed solutions for high-acuity patients and missed opportunities to provide the best care. Story Health offers a new way of treating high morbidity conditions. It is more adaptable, faster to implement, and more effective for both patients and clinicians. Clinicians now have the tools to communicate with patients, manage complex data streams, and make changes to home treatment plans that can have serious consequences. Story Health provides personalized recommendations based upon a patient's story and a clinicians' practice patterns. It's easy to identify patients who need immediate intervention or therapy optimization by looking at patients in between visits.

Our platform is regulatory compliant and allows clinical research to be done by analyzing unstructured EMR data in order to identify life-threatening conditions. We develop technologies that increase access to the most innovative healthcare through clinical trials. Our team is focused on saving lives and providing access to new healthcare therapeutic innovations that are still being investigated. We believe every patient should be informed about their options to participate in clinical trials that could offer therapies that significantly save or improve their lives. We are an AI-based healthcare research company that has developed a platform that uses computational technology to identify patients who meet a complex set criteria and allows them to participate in clinical trials.

OM1 leverages AI and big clinical data to significantly improve research efficiency and clinical decision making through high-performance predictive models. OM1 Patient Finder integrates cutting-edge AI technology with the OM1 Real-World Data Cloud. It uses a variety of data sources to help identify patients most likely to have the target condition. Our intelligent data cloud allows healthcare stakeholders to access, analyze, and use outcome data in a more robust and clinically meaningful way. Access high-quality research-grade information about safety, effectiveness, and value quickly, accurately, and at a lower cost. Quantify outcomes and show value in risk-sharing or outcomes-based payment models

WellAI for Medical Providers - The First Integrated AI Patient Engagement/Digital Front Doors Application with Front Office Optimization One of the first AI/Natural Language Processing Patient Engagement Platforms/Digital Front Door solutions. It offers configurable technology-enabled services that can be integrated with front office workflows, driving efficiency and real-time patient care. Why WellAI's solution: 1. The Digital Health Virtual Triage Assistant has an 83% accuracy rate compared to the 50%-77% accuracy of other'symptom checkers' 2. We offer built-in telehealth and can integrate existing telehealth solutions. This reduces cost and improves engagement 3. WellAI supports 'technology enabled service' in a configurable manner for patients and creates automation for healthcare's front-office workflow. 4. It can be configured in any way you like. 5. It can be integrated with many EMR solutions. 6. It allows practitioners to communicate with each other via email and text.

Amazon Comprehend is a HIPAA-eligible, natural language processing (NLP), service that uses machine-learning to extract health data form medical text. No machine learning experience is necessary. Today, a lot of health data is found in free-form medical texts like doctor's notes, clinical trials reports, and patient records. Manually extracting data can be time-consuming and automated rule-based attempts at extracting data won't capture the whole story because they don't take context into consideration. The data is not usable for large-scale analytics that will help improve the healthcare and life sciences industry, patient outcomes, and increase efficiencies.

Through decades of collaboration with thought leaders, we have made significant progress in tissue data mining tools, precision and workflow. Learn more about image analysis and tissue mining in multi- and highplexed photos, mine your data to find clinically relevant patterns that lead you to disease insight, transform your research tissue images into information. Learn more about image analysis CE/IVD APPs and workflows. And shift the paradigm of standardization with AI-driven pathology products that provide diagnostic decision support. Our app center provides access to a wide range of AI-based apps, as well as APPs that can scale to your needs. Explore our collection of publications, guides and webinars to learn more about digital pathology.

Polyfins Technology Inc, a Silicon Valley startup, uses technologies such as Artificial Intelligence for dermatology problems. It combines mobility and the power of AI to offer a simple-to-use solution that is accessible to both patients and healthcare professionals. To improve access and accuracy of dermatology care in developing and developed countries. Our AI-enabled applications Eczemalesss and Tibot allow users to access high quality skincare information at home. EczemaLess, an AI-enabled app for people with Eczema, is available. It offers a single-stop solution to Eczema, including tracking Eczema severity and managing triggers. Learn what could be triggering your eczema. Evaluate which treatments are most effective for you. Find out the most common triggers, severity and care routine.

MedGeo, a health MedGEO, connects healthcare providers and patients using clinician-developed digital technology. Startup that works directly with industry representatives, administrators and providers to develop software applications that optimize clinical workflows. MedGEO was built on the expertise of global health, medical, and surgical professionals. We bring decades of first-hand knowledge from over 100 countries to the field. Modern hospital corridors are crowded, filled with computers and hardware, and covered with wires. They represent a patchwork system that is often unable to communicate. Staff spend more time interacting with computers than patients, and clinicians spend a lot more time entering data rather than providing care. MedGEO optimizes workflows to benefit clinicians, healthcare administrators and pharmaceutical companies.

InformAI is a healthcare company that focuses on AI solutions for medical diagnosis at the point of care and improving radiologist productivity. The Texas Medical Center is the largest medical center complex in the world. We developed our AI-enabled image classifications and patient outcome predictors. InformAI, along with its partners, is changing the way healthcare is delivered. InformAI partners with leading medical imaging companies, national physician groups, and renowned healthcare organizations to create solutions that improve patient outcomes. Our team includes leaders in healthcare, medicine, and artificial intelligence. InformAI Sinus Image Classifier was built using a 3D convolutional neural net (CNN), which is trained on radiology-validated 3D CT scan image libraries that contain 6 million images.

The revolutionary Soliton®, AI, empowers healthcare. Soliton®, built on 30,000 machine learning and evidence-based rules, automates your healthcare and care management tasks. Soliton®, gives you the edge in the value-based healthcare world with unmatched capabilities. Analyzes large amounts of patient data in real time to improve clinical and financial performance. Multiple APMs supported. Telehealth adds value by predicting billable codes during patient encounters. Multiple risk stratification models can help you predict future healthcare costs for your patients. Real-time clinical decision support that helps you manage complex patient populations. AI-enhanced care coordination streamlines the patient journey and care, from the acute to post-acute environments. Identify care gaps, code and service opportunities, generate patient-specific assessments and personalized care plans and build custom cohorts.

Augnito combines Speech Recognition AI power with mobility. With best-in-class accuracy, Augnito allows you to edit, format, or complete reports at the speed and ease of human speech. You can now access your personal templates and short forms from any computer, whether you're at work, at home, or on the road. This program is best suited for those who need to create detailed reports, such as radiology, histopathology, and surgical notes. You can also dictate your reports from anywhere around the world. Augnito can recognize different accents and pronunciations without any profile training. Augnito is built with the most advanced deep learning technology and has the entire language for medicine that covers 50+ sub-specialties and all the popular generic and drug names.

Speech is a complex process that involves the lungs, upper airways and nerves. Signs in speech and breath can indicate many medical conditions, such as respiratory diseases and infections. Unique auditory signatures can be found in mucus, congestion, inflammation and scarring. Lower respiratory tract infections are responsible for nearly 4 million deaths each year worldwide, even without considering the additional impact of coronavirus. Climate change has led to an increase in wildfires and allergenic pollutants. You can use the phone that you already own without professional assistance. This unique framework captures respiratory sounds in real-world settings. It provides real-time feedback and denoising to improve data quality. Our best-in-class algorithms are powered by dozens of features that are not detectable by the human ear.

At Enlitic, we believe that the power of artificial intelligence can transform healthcare by enabling effective data management and improving clinical workflows. Our mission at Enlitic is to intelligently manage healthcare data using the power of artificial intelligence to expand capacity and improve clinical workflows and create a foundation for a real-world evidence medical image database for healthcare providers. Through our Enlitic Framework, we aim to reimagine healthcare intelligence, enabling healthcare professionals to make informed decisions and provide personalized care to every patient.

Artificial Intelligence and RNA sequencing (RNA–seq data) are both a necessity and a way to develop therapeutics that target splicing mistakes. Machine learning allows us to quickly identify new splicing mistakes and design therapeutic compounds to correct them. SpliceCore, our AI platform for RNA therapeutics research, is what we call SpliceCore. This technology platform was specifically designed for the analysis and interpretation of RNA sequencing data. It can identify, validate and test hypothetical drug targets quicker than traditional methods. Our proprietary database of over 5 million potential RNA-splicing errors is the heart of SpliceCore. It is the world's largest database of splicing mistakes and is used to test all RNA sequencing data that is submitted for analysis. Scalable cloud computing allows us to process large amounts of RNA sequencing data efficiently at a higher speed and lower cost, thereby exponentially accelerating therapeutic innovation.

Our AI technology allows healthcare providers to perform high quality ultrasound exams wherever and whenever patients require them. Ultrasound is a safe and highly effective diagnostic tool. However, it can be difficult to master and requires years of specialized training. Image quality can also vary. The exam requires unnatural hand-eye coordination as well as unintuitive visuals. Traditional ultrasound software doesn’t give instructions on how to move an ultrasound transducer to capture a picture, nor any feedback on the quality of the images being captured. Poor quality images can lead to missed opportunities and misdiagnosis, repeat study, inconsistent interpretation, and even misses. The true value and benefits that ultrasound has to offer have not been fully appreciated. With our technology, any healthcare professional can now capture diagnostic-quality images using ultrasound thanks to AI that guides them through each step of the scanning process.

To integrate with your diabetes management platform, plug'n play API. Personalized therapeutic education. Improved understanding of BGL fluctuations. Real-time prediction to predict risks. This allows for greater personalization and better regulation. Manage complex phases of life with rapid glucose changes. Telemedicine & retrospective analysis. Decision-support for patients. Hillo is currently working on the next versions of its AI technology, a therapeutic recommendation system to anticipate and prevent hypoglycemia and hyperglycemia, whose CE mark class IIB is planned for 2020, and the new generation of artificial pancreas(AP) for 2021, which will help overcome the main limitations of current AP systems thanks to the ultra-personalization provided by machine learning. The CE mark class IIB medical device will be the first self-learning artificial intelligence to predict blood glucose levels.

harrison.ai partners with top healthcare organizations to create AI-as a-medical-device solutions that have a global impact on the health care system and support clinical excellence. We believe that quality healthcare is a fundamental human rights. It should be available to everyone, regardless of where they are located in the world. We combine medical insight with data engineering to make this vision a reality. We also harness the potential of AI (artificial intelligence) to create a better, brighter future in healthcare. We are bringing together the best minds to create a culture that encourages exceptional work and bold, innovative ideas. We are a healthcare AI company led by clinicians that provides accessible and efficient solutions and services. We combine deep learning expertise and clinical experience to create healthcare AI solutions.

Arterys, the AI platform for medical imaging, allows you to integrate leading AI clinical applications into your existing PACS/EHR driven workflow. This makes it an extension of what you do already. AI is real. We improve physician experience, accuracy in diagnosis and treatment, financial performance, and outcomes that are important to patients and providers. Accessible from any valid device via the cloud, it is fast and easy to deploy. There is no need for PHI exchange. It is completely secure. Arterys can be connected to your PACS/RIS/EMR/dictation software. Rapid deployment with minimal infrastructure. Available in over 100 countries. Our elastic cloud GPU architecture speeds up all tasks. You can render 3D files, large multi-dimension data in Gb and run multiple AI applications simultaneously. Image caching and pre-fetch allow for faster loading and analysis.

Sargas Pharmaceutical Adherence and Compliance International (SPAC) has developed a proprietary Chronic Care Management Cloud®, platform (CCM), Drug Adherence®, Medication Therapy Monitor®, (MTM) and Mobile Oncology Medication Therapy Monitor®. This platform keeps physicians and patients involved from the moment treatment begins to the end. This team approach to treatment management not just allows patients to reap maximum benefits and achieve best outcomes, but also reduces healthcare costs. The HIPAA compliant and certified SPAC Chronic Care Manager Physician, Patient, & Pharmacy Portals®, allow for real-time, critical patient information exchange between various providers.

Gesund, the first compliant AI factory in the world, is on a mission of bringing clinical-grade AI solutions onto the market. Our platform audits and verifies 3rd-party medical AI solutions to ensure they are safe, effective, and equitable. This helps us comply with regulatory requirements. Gesund orchestrates all aspects of the AI/ML lifecycle by bringing together models, data and experts in a no code environment. Standardized, unified and diversified data tailored to your ML requirements and regulatory requirements. Gesund.ai evaluates model validation requirements and provides a mix of high-quality, diverse data from its clinical partner sites. Model owner uploads model to Gesund.ai federated validation platform which is located on hospital premises or private cloud. The model is run against a validation data set that was curated by the hospital.

Our AI engine transforms drug discovery. Our discoveries help create better medicines faster. Our AI-enabled discovery portfolio is co-owned and owned by prominent investors. Atomwise developed a machine-learning-based discovery engine that combines the power of convolutional neural networks with massive chemical libraries to discover new small-molecule medicines. People are the key to redefining drug discovery using AI. We are committed to creating the best AI platform possible and using it to transform small-molecule drug discovery. To help drug developers achieve their goals, we have to tackle the most difficult and seemingly impossible targets. We also need to streamline the drug discovery process in order to make it more efficient. The ability to screen trillions of compounds in silica increases the chance of success. Demonstrates exceptional model accuracy, surpassing the challenge of false negatives.

AIDDISON™, a drug discovery software, combines the power and efficiency of artificial intelligence (AI), computer-aided design (CADD), and machine learning (ML) to provide a valuable toolkit that can be used for medicinal chemistry. It is a unified platform that integrates all aspects of virtual screening, including ligand-based design and structure-based design. It also supports methods for in silico lead optimization and discovery.

Morressier offers professional and academic organizations comprehensive virtual and hybrid conference solutions, powerful analytics and new revenue opportunities. More than 200 institutions, societies, and corporations have trusted Morressier since 2014 to support their meetings, engage users, and amplify their research. Morressier's powerful suite and custom integrations allow partners to share, integrate, and host traditionally hidden content such as abstracts, posters and presentations. Morressier facilitates scientific discourse and accelerates scientific breakthroughs by increasing the visibility of early-stage research as well as providing valuable aggregate insights.

Oncoustics develops and deploys patented AI solutions that are low-cost and non-invasive for surveillance, diagnostics and treatment monitoring of high-unmet clinical needs. Oncoustics provides a range of anatomy-focused apps that can be used on any PoC ultrasound. They can also be used by any MD/nurse/tech to provide basic primary care office instruments, without the need for images. Oncoustics' AI solutions transform point-of-care ultrasounds into powerful diagnostic tools that can detect and monitor diseases such as those in the liver, prostate and kidney, breast, thyroid, and other organs. Our team includes experts in AI, signal processing and radiology. Point of care diagnosis and surveillance are cost-effective and improve outcomes. This results in better disease management.

Clara's domain specific tools, AI pretrained models, accelerated applications, and accelerated AI applications are enabling AI advances in many fields, including medical device, imaging, drug discovery and genomics. Holoscan allows you to explore the entire pipeline of medical device deployment and development. With the NVIDIA IGX Developer Kits, you can build containerized AI apps using the Holoscan SDK. The NVIDIA IGX SDK includes pre-trained AI model, healthcare-specific acceleration libraries and reference applications for medical devices.

Waveform AI is a powerful tool that can improve the healthcare system in many ways. We are building a platform to provide clinicians with valuable information and support throughout the care continuum. It takes a village to transform healthcare. We are publishing peer-reviewed AI research to show how AI can benefit every step of the patient's care journey. Providers can help identify patients at high risk of sleep apnea by using data from EMRs, waveforms and wearables. Refer patients to a specialist for diagnosis. Providers can use data to identify the most important patients in the vast undiagnosed population. Patients can be stratified by risk and cost. By optimizing the quality, cost, efficiency, and speed of sleep apnea diagnosis, clinicians can help patients get through the diagnostic process.

Augmedix offers industry-leading medical document solutions that reduce administrative burden and allow clinicians to concentrate on patient care. Ambient medical documentation solutions from the company capture natural clinician-patient conversations at point of care. Augmedix Ambient Automation Platform - Automated Speech Recognition is used to transcribe natural conversations between clinicians, patients, and then - Uses Natural Language Processing and structured models, with support from medical documentation specialists, in order to create medical notes and lastly, - Inserts medical notes into EHR for review by clinicians and signature-off. The solution works on both mobile phones and other mobile hardware devices.

VIPER automates screening from remote patient identification (at point of diagnosis) through to qualified enrollment. VIPER uses artificial intelligence to match patients to precision trials within a narrow window of opportunity. This is done through the ingestion of lab-agnostic genomic and pathology data. It is tailored to the patient and the researcher. VIPER searches the personalized matching engine to locate the best clinical trials available for a patient's specific diagnosis--at that time. VIPER integrates workflow to send real-time notifications to the entire care team about a patient's eligibility in available clinical trials. This is done within a very limited enrollment window. VIPER provides interactive dashboards that allow you to access real-time data mining capabilities to aggregate patient data from both study and site levels to help you reach your study KPIs.

AI Medical Scribe is a tool which listens to the conversation between a clinician and a patient, using AI to simplify documentation. Integration with more than 15 EMRs, with real template matching and customizable features.

Machine learning can do amazing things, including understanding the world, driving cars, writing code, and making art. It's still very difficult to use. Research is usually published in a PDF format. There are also bits of code on GitHub and weights (if you're fortunate!) on Google Drive. It's difficult to apply that work to a real-world problem unless you're an expert. Machine learning is now accessible to everyone. Machine learning models should be shared by people who create them. People who want to use machine-learning should not need a PhD to share their machine learning models. Great power comes with great responsibility. We believe that this technology can be made safer and more understandable by using better tools and safeguards.